Close

Novartis (NVS) Announces Strong Data on Entresto in Heart Event Risk Reduction for HFrEF-Related Heart Failure Patients

Go back to Novartis (NVS) Announces Strong Data on Entresto in Heart Event Risk Reduction for HFrEF-Related Heart Failure Patients